Yahoo! Finance: Top Stories

Canaccord Genuity Keeps Buy Rating on Clover Health (CLOV)

Jun 23, 2025 - 17:54
 0
Canaccord Genuity Keeps Buy Rating on Clover Health (CLOV)
Read More

Tags:

Previous Article

KeyBanc Maintains Overweight Rating on GoodRx (GDRX)

Next Article

Rosenblatt Raises Terawulf (WULF) Price Target, Keeps Buy Rating

Related Posts

H.C. Wainwright Maintains Buy Rating on Tourmaline Bio (TRML) After Promising Phase 2 Results

H.C. Wainwright Maintains Buy Rating on Tourmaline Bio ...

May 30, 2025  0

Ryan Reynolds’ MNTN Shares Rise 65% After $187 Million IPO

Ryan Reynolds’ MNTN Shares Rise 65% After $187 Million IPO

May 24, 2025  0

Job Openings Increased in April. Why That May Not Last.

Job Openings Increased in April. Why That May Not Last.

Jun 3, 2025  0